| # | Drug | Count |
|---|---|---|
| 0 | METFORMIN | 35 |
| 1 | METFORMIN ER 500 MG | 35 |
| 2 | METFORMIN ER 750 MG | 35 |
| 3 | DAPAGLIFLOZIN | 32 |
| 4 | PREDNISONE | 31 |
| 5 | EMPAGLIFLOZIN | 24 |
| 6 | PREDNISOLONE | 22 |
| 7 | PREDNISOLONE ORAL | 22 |
| 8 | PREDNISOLONE ORAL SOLUTION | 22 |
| 9 | IBUPROFEN | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLUCAGON | 9 | 0.0021 |
| 1 | TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM | 11 | 0.0016 |
| 2 | EMPAGLIFLOZIN AND LINAGLIPTIN | 3 | 0.0015 |
| 3 | IOPAMIDOL | 3 | 0.0010 |
| 4 | VASOPRESSIN | 4 | 0.0009 |
| 5 | GLYCOPYRROLATE | 5 | 0.0009 |
| 6 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 3 | 0.0009 |
| 7 | ROCURONIUM BROMIDE | 9 | 0.0007 |
| 8 | POLATUZUMAB VEDOTIN | 7 | 0.0007 |
| 9 | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | 13 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 67 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 46 |
| 2 | Insulin Analog [EPC] | 32 |
| 3 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 29 |
| 4 | Azole Antifungal [EPC] | 21 |
| 5 | Benzodiazepine [EPC] | 21 |
| 6 | GLP-1 Receptor Agonist [EPC] | 21 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 20 |
| 8 | Osmotic Laxative [EPC] | 19 |
| 9 | Glycopeptide Antibacterial [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antihypoglycemic Agent [EPC] | 9 | 0.0021 |
| 1 | Monobactam Antibacterial [EPC] | 2 | 0.0007 |
| 2 | alpha-1 Adrenergic Agonist [EPC] | 3 | 0.0007 |
| 3 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 4 | Pyrethroid [EPC] | 1 | 0.0006 |
| 5 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 7 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 8 | Benzothiazole [EPC] | 1 | 0.0004 |
| 9 | RNA Synthetase Inhibitor Antibacterial [EPC] | 6 | 0.0004 |